Professor Susan Sharfstein (University at Albany) discusses advances in cell line development, from high-throughput screening to transcription-based selection. Maren Grün (Thermo Fisher Scientific) sh ...

In this interview, Dr. Marsh Durban explores how innovations such as controlled seeding and size‑selection are enabling researchers to generate uniform, assay‑ready organoids at scale.

Aleph Farms, a cellular agriculture company developing a scalable biomanufacturing platform for the food and broader bio-based industries, announced the ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these ...

Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...

Solid-state battery developer QuantumScape is off and running in 2026, inaugurating its shiny new Eagle Line for pilot production.